Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study

Hypertension

White-Coat Effect Is Uncommon in Patients With Refractory Hypertension

Hypertension.

Siddiqui M, Judd EK, Oparil S, Calhoun DA

doi: 10.1161/

Cardiovascular Risk and DiseasesHypertension

Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control

N Engl J Med.

Bress AP, Bellows BK, King JB, Hess R, Beddhu S, Zhang Z, Berlowitz DR, Conroy MB, Fine L, Oparil S, Morisky DE, Kazis LE, Ruiz-Negrón N, Powell J, Tamariz L, Whittle J, Wright JT Jr, Supiano MA, Cheung AK, Weintraub WS, Moran AE; SPRINT Research Group

doi: 10.1056/NEJMsa1616035.

Cardiovascular Risk and DiseasesHypertension

Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients with Hypertension: The Systolic Blood Pressure Intervention (SPRINT) Trial

Circulation.

Soliman EZ, Ambrosius WT, Cushman WC, Zhang ZM, Bates JT, Neyra JA, Carson TY, Tamariz L, Ghazi L, Cho ME, Shapiro BP, He J, Fine LJ, Lewis CE; SPRINT Research Study Group

doi: 10.1161/

Hypertension

American Versus European Hypertension Guidelines: The Case of White Coat Hypertension

Am J Hypertens.

Cuspidi C, Paoletti F, Tadic M, Sala C, Dell'Oro R, Grassi G, Mancia G

doi: 10.1093/ajh/hpaa029.

Hypertension

Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT

J Am Heart Assoc.

Ghazi L, Pajewski NM, Rifkin DE, Bates JT, Chang TI, Cushman WC, Glasser SP, Haley WE, Johnson KC, Kostis WJ, Papademetriou V, Rahman M, Simmons DL, Taylor A, Whelton PK, Wright JT, Bhatt UY, Drawz PE

doi: 10.1161/JAHA.118.011706.

Thrombosis and Stroke

Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial

Lancet Neurol

Rapp SR, Gaussoin SA, Sachs BC, Chelune G, Supiano MA, Lerner AJ, Wadley VG, Wilson VM, Fine LJ, Whittle JC, Auchus AP, Beddhu S, Berlowitz DR, Bress AP, Johnson KC, Krousel-Wood M, Martindale-Adams J, Miller EC, Rifkin DE, Snyder JK, Tamariz L, Wolfgram DF, Cleveland ML, Yang M, Nichols LO, Bryan RN, Reboussin DM, Williamson JD, Pajewski NM, SPRINT Research Group.

doi: 10.1016/S1474-4422(20)30319-7

Cardiovascular Risk and DiseasesHypertension

Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension

J Am Coll Cardiol.

Phillips RA, Xu J, Peterson LE, Arnold RM, Diamond JA, Schussheim AE

doi: 10.1016/j.jacc.2018.01.074.

Cardiovascular Risk and DiseasesHypertension

Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes

N Engl J Med.

Berlowitz DR, Foy CG, Kazis LE, Bolin LP, Conroy MB, Fitzpatrick P, Gure TR, Kimmel PL, Kirchner K, Morisky DE, Newman J, Olney C, Oparil S, Pajewski NM, Powell J, Ramsey T, Simmons DL, Snyder J, Supiano MA, Weiner DE, Whittle J; SPRINT Research Group

doi: 10.1056/NEJMoa1611179.

Hypertension

Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions

JAMA.

SPRINT MIND Investigators for the SPRINT Research Group., Nasrallah IM, Pajewski NM, Auchus AP, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Doshi J, Erus G, Fine LJ, Gaussoin SA, Harris D, Johnson KC, Kimmel PL, Kurella Tamura M, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT Jr, Wright CB, Williamson JD, Bryan RN

doi: 10.1001/jama.2019.10551.

Related content

White-Coat Effect Is Uncommon in Patients With Refractory Hypertension

Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control

Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients with Hypertension: The Systolic Blood Pressure Intervention (SPRINT) Trial

American Versus European Hypertension Guidelines: The Case of White Coat Hypertension

Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT

Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial

Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension

Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes

Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions